1-5 of 5
Kyung-Hun Lee
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer

Joanne L. Blum, A. Douglas Laird, Jennifer K. Litton, Hope S. Rugo, Johannes Ettl, Sara A. Hurvitz, Miguel Martin, Henri H. Roché, Kyung-Hun Lee, Annabel Goodwin, Ying Chen, Silvana Lanzalone, Jijumon Chelliserry, Akos Czibere, Julia F. Hopkins, Lee A. Albacker, Lida A. Mina
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1383–1390.
https://doi.org/10.1158/1078-0432.CCR-21-2080
Published: 01 April 2022
View article titled, Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline <em>BRCA1/2</em>-Mutated Breast Cancer
Open the PDF for Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline <em>BRCA1/2</em>-Mutated Breast Cancer in another window
Includes: Supplementary data
Journal Articles

Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib

Dae-Won Lee, Eun Ju Cho, Jeong-Hoon Lee, Su Jong Yu, Yoon Jun Kim, Jung-Hwan Yoon, Tae-Yong Kim, Sae-Won Han, Do-Youn Oh, Seock-Ah Im, Tae-You Kim, Youngeun Lee, Haeryoung Kim, Kyung-Hun Lee
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (3): 713–718.
https://doi.org/10.1158/1078-0432.CCR-20-3094
Published: 01 February 2021
View article titled, Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib
Open the PDF for Phase II Study of Avelumab in Patients with Advanced Hepatocellular Carcinoma Previously Treated with Sorafenib in another window
Journal Articles

Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer

Chan-Young Ock, Keun-Wook Lee, Jin Won Kim, Jin-Soo Kim, Tae-Yong Kim, Kyung-Hun Lee, Sae-Won Han, Seock-Ah Im, Tae-You Kim, Woo Ho Kim, Yung-Jue Bang, Do-Youn Oh
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (11): 2520–2529.
https://doi.org/10.1158/1078-0432.CCR-14-2659
Published: 31 May 2015
View article titled, Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer
Open the PDF for Optimal Patient Selection for Trastuzumab Treatment in HER2-Positive Advanced Gastric Cancer in another window
Includes: Supplementary data
Journal Articles

High Fluorodeoxyglucose Uptake on Positron Emission Tomography in Patients with Advanced Non–Small Cell Lung Cancer on Platinum-Based Combination Chemotherapy

Kyung-Hun Lee, Se-Hoon Lee, Dong-Wan Kim, Won Jun Kang, June-Key Chung, Seock-Ah Im, Tae-You Kim, Young Whan Kim, Yung-Jue Bang, Dae Seog Heo
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (14): 4232–4236.
https://doi.org/10.1158/1078-0432.CCR-05-2710
Published: 20 July 2006
View article titled, High Fluorodeoxyglucose Uptake on Positron Emission Tomography in Patients with Advanced Non–Small Cell Lung Cancer on Platinum-Based Combination Chemotherapy
Open the PDF for High Fluorodeoxyglucose Uptake on Positron Emission Tomography in Patients with Advanced Non–Small Cell Lung Cancer on Platinum-Based Combination Chemotherapy in another window
Journal Articles

Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation

Sae-Won Han, Tae-You Kim, Yoon Kyung Jeon, Pil Gyu Hwang, Seock-Ah Im, Kyung-Hun Lee, Jee Hyun Kim, Dong-Wan Kim, Dae Seog Heo, Noe Kyeong Kim, Doo Hyun Chung, Yung-Jue Bang
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (8): 2538–2544.
https://doi.org/10.1158/1078-0432.CCR-05-2845
Published: 25 April 2006
View article titled, Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation
Open the PDF for Optimization of Patient Selection for Gefitinib in Non–Small Cell Lung Cancer by Combined Analysis of Epidermal Growth Factor Receptor Mutation, K-ras Mutation, and Akt Phosphorylation in another window